Earnings History Data for Cue Biopharma (CUE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cue Biopharma

Cue Biopharma, Inc. is an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. Cue Biopharma, Inc. is headquartered in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
16-03-2026	AH		CUE	Cue Biopharma	24.00	0.01	-0.10	0.00	Cue Biopharma GAAP EPS of $0.01, revenue of $21.94M [3/17/2026 10:48 AM]	0.2707	-0.04 (-13.10%)	0.29	-0.02 (-5.62%)	0.23 - 1.05	4,330,006	3,300,000	3,959,859
Cue Biopharma GAAP EPS of $0.01, revenue of $21.94M [3/17/2026 10:48 AM]
12-08-2025	AH		CUE	Cue Biopharma	63.00	-0.09	-0.13	0.00	Cue Biopharma GAAP EPS of -$0.09, revenue of $2.95M [8/12/2025 4:48 PM]	0.80	0.01 (1.27%)	0.80	0.01 (0.86%)	0.45 - 1.99	81,640	130,000	486
Cue Biopharma GAAP EPS of -$0.09, revenue of $2.95M [8/12/2025 4:48 PM]
12-05-2025	AH		CUE	Cue Biopharma	47.00	-0.17	-0.14	0.00	Cue Biopharma GAAP EPS of -$0.17 misses by $0.02, revenue of $0.42M misses by $0.85M [5/12/2025 5:27 PM]	0.7638	0.01 (1.70%)	0.75	0.0 (-0.40%)	0.45 - 1.99	259,417	110,000	2,253
Cue Biopharma GAAP EPS of -$0.17 misses by $0.02, revenue of $0.42M misses by $0.85M [5/12/2025 5:27 PM]
31-03-2025	AH		CUE	Cue Biopharma	63.00	-0.13	-0.16	0.00	Cue Biopharma GAAP EPS of -$0.13 beats by $0.03, revenue of $1.58M misses by $0.12M [3/31/2025 5:24 PM]	0.76	-0.15 (-16.58%)	0.91	0.0 (0.00%)	0.45 - 2.26	364,522	90,000	325
Cue Biopharma GAAP EPS of -$0.13 beats by $0.03, revenue of $1.58M misses by $0.12M [3/31/2025 5:24 PM] Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights [2025-03-31 04:20PM] ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates [Mar-28-25 09:15AM] Cue Biopharma, Inc. (CUE) Reports Q4 Loss, Misses Revenue Estimates [2025-03-31 05:15PM]
14-11-2024	PM		CUE	Cue Biopharma, Inc.	82.69	-0.17	-0.20	-0.24	Cue Biopharma GAAP EPS of -$0.17 beats by $0.02, revenue of $3.34M beats by $1.82M [11/15/2024 5:06 AM]	1.25	-0.25 (-16.67%)	1.47	-0.03 (-1.78%)	0.45 - 3.25	1,191,766	730,000	1,068
Cue names Daniel Baker interim CDO, CSO Anish Suri to transition to advisor role [11/14/2024 8:33 AM] Cue Biopharma GAAP EPS of -$0.1, revenue of $3.34M [11/15/2024 5:06 AM] Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates [Nov-14-24 05:25PM] Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Nov-14-24 04:05PM] Cue Biopharma Announces Strategic Organizational Transition [Nov-14-24 08:00AM]
09-05-2024	AH		CUE	Cue Biopharma	106.00	-0.25	-0.30	0.00	Cue Biopharma GAAP EPS of -$0.25 beats by $0.03, revenue of $1.7M beats by $0.49M [5/9/2024 6:04 PM]	1.75	-0.17 (-8.62%)	0.0	0.0 (0.00%)	1.30 - 5.12	433,922	420,000	0
Cue Biopharma GAAP EPS of -$0.25 beats by $0.03, revenue of $1.7M beats by $0.49M [5/9/2024 6:04 PM]
08-08-2023	AH		CUE	Cue Biopharma, Inc.	154.58	-0.29	-0.30	-0.37	Cue Biopharma GAAP EPS of -$0.29 beats by $0.01, revenue of $1.38M beats by $0.47M [8/9/2023 4:50 PM]	3.13	-0.49 (-13.54%)	0.0	0.0 (0.00%)	2.18 - 5.12	1,196,099	340,000	0
Cue Biopharma GAAP EPS of -$0.29 beats by $0.01, revenue of $1.38M beats by $0.47M [8/9/2023 4:50 PM]
14-11-2022	AH		CUE	Cue Biopharma	110.00	-0.31	-0.38	0.00	Cue Biopharma GAAP EPS of -$0.31 beats by $0.07, revenue of $0.07M misses by $0.37M [11/14/2022 5:35 PM]	3.88	0.62 (19.23%)	3.30	0.05 (1.54%)	2.18 - 18.42	369,048	170,000	2,134
Cue Biopharma GAAP EPS of -$0.31 beats by $0.07, revenue of $0.07M misses by $0.37M [11/14/2022 5:35 PM] Cue Biopharma Reports Third Quarter 2022 Financial Results [Nov-14-22 04:01PM] Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing [Nov-14-22 08:20AM]
10-05-2022	AH		CUE	Cue Biopharma	130.00	-0.44	-0.43	0.00	Cue Biopharma GAAP EPS of -$0.44 misses by $0.02, revenue of $1M misses by $1.92M [5/10/2022 5:03 PM]	3.54	-0.65 (-15.60%)	4.25	0.05 (1.19%)	3.30 - 18.42	1,170,486	350,000	55,557
Cue Biopharma GAAP EPS of -$0.44 misses by $0.02, revenue of $1M misses by $1.92M [5/10/2022 5:03 PM] Cue Biopharma IND application for cancer candidate CUE-102 accepted by FDA [5/11/2022 9:11 AM] Cue Biopharma Reports First Quarter 2022 Financial Results [May-10-22 04:30PM] A Cue Biopharma, Inc. (NASDAQ:CUE) insider increased their holdings by 6.5% last year [May-10-22 11:23AM] Cue Biopharma Receives FDA Acceptance of Investigational New Drug (IND) Application for CUE-102 in Wilms Tumor 1 (WT1) - expressing cancers [May-11-22 08:00AM]
17-05-2021	AH		CUE	Cue Biopharma, Inc.	407.00	-0.41	-0.37	0.00	Cue Biopharma EPS misses by $0.02, beats on revenue [5/17/2021 4:20 PM]	13.46	-0.54 (-3.86%)	14.00	0.0 (0.00%)	10.69 - 31.69	339,819	1,630,000	6,296
Cue Biopharma EPS misses by $0.02, beats on revenue [5/17/2021 4:20 PM] Cue Biopharma Reports First Quarter 2021 Results, Recent Updates of CUE-101 Phase 1 Dose Escalation Study, Platform Progress and Business Highlights [May-17-21 04:01PM]
16-03-2021	AH	4:00 PM ET (Mar 16)	CUE	Cue Biopharma, Inc.	479.70	-0.37	-0.33	-0.37	Cue Biopharma EPS beats by $0.03, misses on revenue [3/16/2021 4:56 PM]	13.95	-0.87 (-5.87%)	14.82	0.89 (6.39%)	9.30 - 31.69	238,847	427,260	0
Cue Biopharma EPS beats by $0.03, misses on revenue [3/16/2021 4:56 PM] Cue Biopharma to Present Corporate Overview and Clinical Progress at the Upcoming Oppenheimer 31st Annual Healthcare Conference [Mar-15-21 08:00AM] Cue Biopharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights [Mar-16-21 04:01PM]
17-11-2020	AH		CUE	Cue Biopharma, Inc.	361.00	-0.34	-0.37	0.00	Cue Biopharma EPS beats by $0.12, misses on revenue [11/17/2020 4:07 PM]	12.51	0.96 (8.31%)	11.55	0.0 (0.00%)	8.73 - 31.69	307,172	193,567	10,068

17-11-2020	AH		CUE	Cue Biopharma, Inc.	354.56	-0.34	-0.37	-0.31	Cue Biopharma EPS beats by $0.12, misses on revenue [11/17/2020 4:07 PM]	12.22	-0.48 (-3.78%)	12.70	0.0 (0.00%)	9.11 - 31.69	173,211	216,720	5,664
Cue Biopharma reports Q3 results, issues update to lead program [11/18/2020 12:22 PM]